Skip to main content
. 2018 Mar 27;62(4):e00047-18. doi: 10.1128/AAC.00047-18

TABLE 1.

Summary of the in vitro activity of OMC and comparators against anaerobes

graphic file with name zac00418-7071-t01.jpg

a

OMC, omadacycline; TGC, tigecycline; MEM, meropenem; MXF, moxifloxacin; CLI, clindamycin; MTZ, metronidazole; TZP, piperacillin-tazobactam (tazobactam was tested at a constant concentration of 4 μg/ml; the piperacillin MICs are shown).

b

MIC values were interpreted based on CLSI breakpoints (6) except for those of tigecycline, which were interpreted based on FDA prescribing information for Tygacil (7). S, susceptible; I, intermediate; R, resistant.